Monopar Therapeutics (MNPR) had the highest return between December 14, 2019 and December 21, 2019 by a small-cap US stock or small-cap US stock, returning 223.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Monopar Therapeutics (MNPR) | 12/14/2019 - 12/21/2019 | 223.35% |
Gyre Therapeutics (GYRE) | 12/14/2019 - 12/21/2019 | 51.53% |
Tetra Technologies (TTI) | 12/14/2019 - 12/21/2019 | 40.15% |
Lsb Industries (LXU) | 12/14/2019 - 12/21/2019 | 36.06% |
Mama's Creations (MAMA) | 12/14/2019 - 12/21/2019 | 32.45% |
Cerence (CRNC) | 12/14/2019 - 12/21/2019 | 31.09% |
Euroseas (ESEA) | 12/14/2019 - 12/21/2019 | 26.27% |
Lightbridge (LTBR) | 12/14/2019 - 12/21/2019 | 26.23% |
Arbutus Biopharma (ABUS) | 12/14/2019 - 12/21/2019 | 23.5% |
Concrete Pumping Holdings Class A (BBCP) | 12/14/2019 - 12/21/2019 | 23.35% |
Prothena (PRTA) | 12/14/2019 - 12/21/2019 | 23.25% |
CytomX Therapeutics (CTMX) | 12/14/2019 - 12/21/2019 | 22.59% |
FuelCell Energy (FCEL) | 12/14/2019 - 12/21/2019 | 21.88% |
Cresud SACIF y A (CRESY) | 12/14/2019 - 12/21/2019 | 21.87% |
Corvus Pharmaceuticals (CRVS) | 12/14/2019 - 12/21/2019 | 19.5% |
Nabors Industries (NBR) | 12/14/2019 - 12/21/2019 | 19.2% |
Nordic American Tankers (NAT) | 12/14/2019 - 12/21/2019 | 19.07% |
Pennant (PNTG) | 12/14/2019 - 12/21/2019 | 17.89% |
Fulcrum Therapeutics (FULC) | 12/14/2019 - 12/21/2019 | 17.53% |
IDT (IDT) | 12/14/2019 - 12/21/2019 | 16.69% |
Clearpoint Neuro (CLPT) | 12/14/2019 - 12/21/2019 | 16.34% |
InnovAge (INNV) | 12/14/2019 - 12/21/2019 | 16.28% |
Ardelyx (ARDX) | 12/14/2019 - 12/21/2019 | 15.71% |
Northern Oil & Gas (NOG) | 12/14/2019 - 12/21/2019 | 15.71% |
RAPT Therapeutics (RAPT) | 12/14/2019 - 12/21/2019 | 15.6% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
